Back
Tarsus Pharmaceuticals Vs. BioCryst Pharmaceuticals Industry Stock Comparison
Buy
58
TARS
Tarsus Pharmaceuticals
Last Price:
32.54
Seasonality Move:
3.41%
Sell
34
BCRX
BioCryst Pharmaceuticals
Last Price:
7.97
Seasonality Move:
-9.69%
Buy
58
Tarsus Pharmaceuticals (TARS)
is a Buy
Is Tarsus Pharmaceuticals a Buy, Sell or Hold?
- The current Tarsus Pharmaceuticals [TARS] share price is $31.05. The Score for TARS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- TARS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
BioCryst Pharmaceuticals (BCRX)
is a Sell
Is BioCryst Pharmaceuticals a Buy, Sell or Hold?
- The current BioCryst Pharmaceuticals [BCRX] share price is $7.92. The Score for BCRX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- BCRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TARS Stock Price Chart
What is Tarsus Pharmaceuticals's stock price today?
-
The Tarsus Pharmaceuticals share price today is $31.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TARS is experiencing slight selling pressure.
BCRX Stock Price Chart
What is BioCryst Pharmaceuticals's stock price today?
-
The BioCryst Pharmaceuticals share price today is $7.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCRX is experiencing slight selling pressure.
TARS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.53 | Buy |
| Relative Strength Index (14 RSI): | 58.42 | Buy |
| Chaikin Money Flow: | -99871 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.83 - 30.71) | Buy |
| Bollinger Bands (100): | (25.51 - 34.31) | Buy |
BCRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 51.08 | Buy |
| Chaikin Money Flow: | -679989 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.72 - 8.3) | Sell |
| Bollinger Bands (100): | (5.72 - 7.88) | Buy |
TARS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.61 | Sell |
| 20-day SMA: | 28.72 | Buy |
| 50-day SMA: | 27.18 | Buy |
| 200-day SMA: | 29 | Buy |
| 8-day EMA: | 31.12 | Sell |
| 20-day EMA: | 29.41 | Buy |
| 50-day EMA: | 28.42 | Buy |
| 200-day EMA: | 27.6 | Buy |
BCRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.82 | Buy |
| 20-day SMA: | 8.07 | Sell |
| 50-day SMA: | 7.68 | Buy |
| 200-day SMA: | 6.16 | Buy |
| 8-day EMA: | 7.91 | Buy |
| 20-day EMA: | 7.94 | Sell |
| 50-day EMA: | 7.6 | Buy |
| 200-day EMA: | 6.74 | Buy |
Tarsus Pharmaceuticals Earnings Growth & TARS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.21 per share, an increase this year of $0.98 per share, and an increase next year of $0.74 per share.
BioCryst Pharmaceuticals Earnings Growth & BCRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.23 per share.
Tarsus Pharmaceuticals Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BioCryst Pharmaceuticals Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||